Scholarlink

Background <p>Down syndrome (DS) is associated with a higher risk of diseases linked to advanced glycation end products (AGEs) accumulation.</p> Objective <p>To evaluate serum AGEs and their soluble receptor (sRAGE) levels in children and adolescents with DS and explore associations with anthropometric and biochemical variables.</p> Methods <p>A cross-sectional study compared 51 DS participants (ages 3–18) with an age-matched control group (<i>n</i> = 51). Anthropometric measurements, blood chemistry, and lipid profiles were assessed. AGEs and sRAGE concentrations were determined by fluorescence and ELISA, respectively.</p> Results <p>DS individuals showed an unfavorable lipid profile, with higher triglycerides and lower HDL-C than controls. AGEs concentrations were significantly elevated in DS compared to controls (2.01 ± 0.48 vs. 1.33 ± 0.26 FAU/µg/mL; <i>p</i> &lt; 0.001), while sRAGE levels were reduced (761.3 ± 433.7 vs. 1,196 ± 411.5 pg/mL; <i>p</i> &lt; 0.001). The AGEs/sRAGE ratio was three times higher in the DS group than in controls (3.5 ± 1.9 vs. 1.2 ± 0.4; <i>p</i> &lt; 0.001). Regression analysis identified HbA1c as a strong predictor of increased AGEs in both groups.</p> Conclusion <p>Individuals with DS have an increased risk of dyslipidemia. Additionally, the elevated AGEs/sRAGE ratio associated with this genetic condition may reduce the protective effect of sRAGE against inflammatory processes.</p> Impact statement <p><UnorderedList Mark="Bullet"> <ItemContent> <p>This is the first study to evaluate the AGEs/sRAGE ratio alongside biochemical and anthropometric markers in individuals with Down syndrome.</p> </ItemContent> <ItemContent> <p>DS individuals are at higher risk for dyslipidemia (elevated triglycerides, low HDL-C) and obesity, potentially linked to altered AGEs and sRAGE dynamics.</p> </ItemContent> <ItemContent> <p>Lower levels of sRAGE in DS may weaken its protective effects against tissue damage and inflammation caused by AGEs accumulation.</p> </ItemContent> <ItemContent> <p>HbA1c emerged as a strong predictor of AGEs, sRAGE, and the AGEs/sRAGE ratio in the DS cohort, highlighting the importance of monitoring glycemic control.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Increased AGEs/sRAGE ratio and dyslipidemia risk in Down syndrome youths: a cross-sectional study

  • 期刊论文

  • 发表日期：

    2025年2月10日

查看全文
  • Wendy P. Gastélum Espinoza,
  • Alma M. Guadrón Llanos,
  • Kenia K. Esparza Ocampo,
  • Jesús M. Pérez Villareal,
  • Verónica J. Picos Cárdenas,
  • Loranda Calderón Zamora,
  • Marco A. Valdés Flores,
  • Alberto K. De la Herrán Arita,
  • Mayra Arias Gastélum,
  • Javier A. Magaña Gómez

摘要

Background

Down syndrome (DS) is associated with a higher risk of diseases linked to advanced glycation end products (AGEs) accumulation.

Objective

To evaluate serum AGEs and their soluble receptor (sRAGE) levels in children and adolescents with DS and explore associations with anthropometric and biochemical variables.

Methods

A cross-sectional study compared 51 DS participants (ages 3–18) with an age-matched control group (n = 51). Anthropometric measurements, blood chemistry, and lipid profiles were assessed. AGEs and sRAGE concentrations were determined by fluorescence and ELISA, respectively.

Results

DS individuals showed an unfavorable lipid profile, with higher triglycerides and lower HDL-C than controls. AGEs concentrations were significantly elevated in DS compared to controls (2.01 ± 0.48 vs. 1.33 ± 0.26 FAU/µg/mL; p < 0.001), while sRAGE levels were reduced (761.3 ± 433.7 vs. 1,196 ± 411.5 pg/mL; p < 0.001). The AGEs/sRAGE ratio was three times higher in the DS group than in controls (3.5 ± 1.9 vs. 1.2 ± 0.4; p < 0.001). Regression analysis identified HbA1c as a strong predictor of increased AGEs in both groups.

Conclusion

Individuals with DS have an increased risk of dyslipidemia. Additionally, the elevated AGEs/sRAGE ratio associated with this genetic condition may reduce the protective effect of sRAGE against inflammatory processes.

Impact statement

This is the first study to evaluate the AGEs/sRAGE ratio alongside biochemical and anthropometric markers in individuals with Down syndrome.

DS individuals are at higher risk for dyslipidemia (elevated triglycerides, low HDL-C) and obesity, potentially linked to altered AGEs and sRAGE dynamics.

Lower levels of sRAGE in DS may weaken its protective effects against tissue damage and inflammation caused by AGEs accumulation.

HbA1c emerged as a strong predictor of AGEs, sRAGE, and the AGEs/sRAGE ratio in the DS cohort, highlighting the importance of monitoring glycemic control.